1123 Remission and Lupus Low Disease Activity State (LLDAS) are associated with a lower probability of flares in Systemic Lupus Erythematosus (SLE) patients. Data from the almenara lupus cohort

1123 Remission and Lupus Low Disease Activity State (LLDAS) are associated with a lower probability of flares in Systemic Lupus Erythematosus (SLE) patients. Data from the almenara lupus cohort

Bibliographic Details
Main Authors:	Graciela S Alarcón, Claudia Elera-Fitzcarrald, Cristina Reátegui-Sokolova, Mariela Medina, Zoila Rodriguez-Bellido, Manuel F Ugarte-Gil, Rocio V Gamboa-Cárdenas, Víctor Pimentel-Quiroz, Risto Perich-Campos, César Pastor-Asurza
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-11-01
Series:	Lupus Science and Medicine

Similar Items

Severe flares are associated with a poorer health-related quality of life (HRQoL) in patients with SLE: data from the Almenara Lupus Cohort
by: Manuel Francisco Ugarte-Gil, et al.
Published: (2022-05-01)

A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort
by: Manuel Francisco Ugarte-Gil, et al.
Published: (2023-01-01)

O37 Male gender, educational level, disease activity, prednisone daily dose and previous medical adherence are predictive of medical adherence in systemic lupus erythematosus patients – Data from the Almenara lupus cohort
by: Graciela S Alarcón, et al.
Published: (2024-03-01)

LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
by: Francisco Zevallos, et al.
Published: (2022-07-01)

LSO-059 Systemic lupus erythematosus (SLE) patients in Auckland: epidemiology and attainment of lupus low disease activity state (LLDAS)
by: Sunil Kumar, et al.
Published: (2023-07-01)

Targeting DORIS Remission and LLDAS in SLE: A Review
by: Agner R. Parra Sánchez, et al.
Published: (2023-10-01)

P85 Predictors of LLDAS and remission in a single-center cohort of patients with lupus nephritis: A retrospective analysis
by: Alessandra Bortoluzzi, et al.
Published: (2024-03-01)

P23 Presence of anti-Sm autoantibodies is associated with abatement of attainability of LLDAS and DORIS remission in systemic lupus erythematosus
by: Ioannis Parodis, et al.
Published: (2024-03-01)

PO.6.121 Epistemic injustice and educational needs for self-management in systemic lupus erythematosus
by: S Ibañez, et al.
Published: (2022-10-01)

AN OVERVIEW OF KNOWLEDGE LEVEL REGARDING THE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN PEOPLE WITH LUPUS (ODAPUS)
by: Farah Azwinda, et al.
Published: (2022-11-01)

Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus
by: Matteo Piga, et al.
Published: (2017-11-01)

Involvement of Gut Microbiota in SLE and Lupus Nephritis
by: Rozita Mohd, et al.
Published: (2023-02-01)

Epidemiologi ved systemisk lupus erythematosus (SLE)
by: Inge-Margrethe Gilboe
Published: (2008-01-01)

Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE)
by: Gabriella Moroni, et al.
Published: (2010-01-01)

Epigenetically Altered T Cells Contribute to Lupus Flares
by: Bruce Richardson
Published: (2019-02-01)

Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study
by: Yoshia Miyawaki, et al.
Published: (2021-03-01)

Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE
by: Jun Kang, et al.
Published: (2023-11-01)

Prolactina e macroprolactina no lúpus eritematoso sistêmico (LES) Prolactin and macroprolactin in systemic lupus erythematosus (SLE)
by: Fabiane Tiskievicz, et al.
Published: (2005-06-01)

Quality of Life in Patient with Systemic Lupus Erythematosus (SLE)
by: Irma Yanih
Published: (2016-11-01)

Canadian workplace experiences of systemic lupus erythematosus (SLE)
by: Ann E Clarke, et al.
Published: (2021-11-01)

Chylous Ascites in Systemic Lupus Erythematosus (SLE) Patients
by: Vital Manuel Da Silva Domingues, et al.
Published: (2015-07-01)

Miliary tuberculosis mimicking systemic lupus erythematosus flare
by: Fatehi Elzein, et al.
Published: (2018-01-01)

Low serum uromodulin levels and their association with lupus flares.
by: Bonilla-Lara David, et al.
Published: (2022-01-01)

Is rituximab effective for induction of remission in lupus nephritis?
by: Macarena Mac-Namara, et al.
Published: (2014-08-01)

Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV
by: Hironari Hanaoka, et al.
Published: (2018-05-01)

Psychiatric disorders in systemic lupus erythematosus (SLE): a serious SLE-related crime
by: Gabriele Nicolosi, et al.
Published: (2013-04-01)

Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE
by: Mileka Gilbert, et al.
Published: (2021-08-01)

A Calibrated Ensemble Algorithm to Address Data Heterogeneity in Machine Learning: An Application to Identify Severe SLE Flares in Lupus Patients
by: Yijun Zhao, et al.
Published: (2022-01-01)

Urinary Aspergillosis in a Patient with Systemic Lupus Erythematosus (SLE)
by: Mayara Gabriele Toledo, et al.
Published: (2023-01-01)

Colonic basidiobolomycosis in a patient with systemic lupus erythematosus (SLE)
by: Elham Barahimi, et al.
Published: (2022-09-01)

622 Childhood-onset SLE Outcomes in the CARRA Lupus Registry
by: Laura Schanberg, et al.
Published: (2022-12-01)

Interferon alpha (IFN-α) in systemic lupus erythematosus (SLE)
by: Sara Moqbil, et al.
Published: (2022-11-01)

Hacking systemic lupus erythematosus (SLE): outcomes of the Waterlupus hackathon
by: Francesca S. Cardwell, et al.
Published: (2020-01-01)

Sex differences in monocyte activation in systemic lupus erythematosus (SLE).
by: Wei Jiang, et al.
Published: (2014-01-01)

PO.4.92 Taxonomy, treatment, targets and remission in systemic lupus erythematosus: the 3TR-SLE study protocol
by: AE Voskuyl, et al.
Published: (2022-10-01)

Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE
by: Chunzhen Li, et al.
Published: (2022-08-01)

Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)
by: Vibeke Strand, et al.
Published: (2022-07-01)

Remission and long-term remission of pediatric-onset systemic lupus erythematosus
by: Yi-Chieh Chen, et al.
Published: (2023-10-01)

P130 Patients’ thoughts of triggers for lupus onset and flares
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

Novel biomarkers in the differential diagnosis of preeclampsia and lupus flare in pregnancy
by: Ilinca Ilie, et al.
Published: (2022-06-01)